| Primary |
|
| Toxicity To Various Agents |
100.0% |
|
| Secondary |
| Plasma Cell Myeloma |
27.6% |
| Hodgkin's Disease |
18.4% |
| Product Used For Unknown Indication |
13.2% |
| Amyloidosis |
6.6% |
| Acute Lymphocytic Leukaemia |
5.7% |
| Multiple Myeloma |
5.3% |
| Nosocomial Infection |
4.8% |
| Premedication |
2.6% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
| Osteoporosis |
2.2% |
| Fungal Infection |
1.8% |
| Musculoskeletal Pain |
1.3% |
| Pancreatic Carcinoma |
1.3% |
| Prostate Cancer |
1.3% |
| Anaplastic Large-cell Lymphoma |
0.9% |
| Chemotherapy |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Hyperthyroidism |
0.9% |
| Idiopathic Thrombocytopenic Purpura |
0.9% |
| Lung Neoplasm Malignant |
0.9% |
|
| Vomiting |
11.9% |
| Rash |
9.5% |
| Toxicity To Various Agents |
9.5% |
| Diarrhoea |
7.1% |
| Platelet Count Decreased |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Deep Vein Thrombosis |
4.8% |
| Hyperglycaemia |
4.8% |
| Neutropenia |
4.8% |
| Oedema Peripheral |
4.8% |
| Pancytopenia |
4.8% |
| Respiratory Disorder |
4.8% |
| Acanthamoeba Infection |
2.4% |
| Acute Lymphocytic Leukaemia |
2.4% |
| Anosmia |
2.4% |
| Bladder Cancer |
2.4% |
| Blindness Unilateral |
2.4% |
| Blood Pressure Increased |
2.4% |
| Cardiac Arrest |
2.4% |
| Cellulitis |
2.4% |
|
| Concomitant |
| Plasma Cell Myeloma |
72.1% |
| Non-small Cell Lung Cancer |
4.5% |
| Colorectal Cancer Metastatic |
3.6% |
| Acute Lymphocytic Leukaemia |
3.3% |
| Multiple Myeloma |
2.8% |
| Product Used For Unknown Indication |
2.8% |
| Breast Cancer |
1.4% |
| Ovarian Cancer |
1.1% |
| Acute Myeloid Leukaemia |
0.9% |
| Chronic Lymphocytic Leukaemia |
0.8% |
| Heart Block Congenital |
0.8% |
| Prophylaxis Of Nausea And Vomiting |
0.8% |
| Adenocarcinoma Of Colon |
0.6% |
| Colon Cancer Metastatic |
0.6% |
| Drug Use For Unknown Indication |
0.6% |
| Eye Infection Toxoplasmal |
0.6% |
| Glioblastoma |
0.6% |
| Neoplasm Malignant |
0.6% |
| Non-hodgkin's Lymphoma |
0.6% |
| Small Cell Lung Cancer |
0.6% |
|
| Pneumonia |
10.6% |
| White Blood Cell Count Decreased |
9.1% |
| Plasma Cell Myeloma |
6.8% |
| Deep Vein Thrombosis |
6.5% |
| Rash |
6.5% |
| Thrombocytopenia |
6.1% |
| Thrombosis |
5.7% |
| Platelet Count Decreased |
5.3% |
| Pancytopenia |
4.9% |
| Tremor |
4.9% |
| Fatigue |
3.8% |
| Pulmonary Embolism |
3.8% |
| Pyrexia |
3.8% |
| Syncope |
3.8% |
| Vomiting |
3.8% |
| Urticaria |
3.4% |
| Pruritus |
3.0% |
| Urinary Tract Infection |
3.0% |
| Weight Decreased |
2.7% |
| Dyspnoea |
2.3% |
|
